United States Healthcare Equipment & Supplies

Carlsmed Inc (CARL)

Track

Track

Carlsmed Inc experienced significant insider activity on March 2, 2026, when CEO Michael Cordonnier executed a sale of 197,855 shares. This follows a series of substantial acquisitions by various stakeholders during July 2025. No further transactions have been recorded within the most recent three-month period.
Ticker: CARL Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Carlsmed Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.2
Cordonnier Michael CEO, President Executive Director
Transaction date
Sale
Price
28.48
Quantity 34,521 -28.6%
Value US$3,486,864
3.2
Cordonnier Michael Officer; Director Executive Director
Transaction date
Proposed sale
Price
472.77
Quantity 38,958
Value US$1,093,404
0.8
Mittendorff Robert II Non-Executive Director
Transaction date
Purchase
Price
15.00
Quantity 1,333,333 +36.2%
Value US$19,999,995
0.8
Sidow Kevin Non-Executive Director
Transaction date
Purchase
Price
15.00
Quantity 13,333 +28.8%
Value US$199,995
2.6
ROOT JONATHAN D Non-Executive Director
Transaction date
Purchase
Price
15.00
Quantity 466,666 +2692.4%
Value US$6,999,990
0.8
YOUNG PHILIP M Non-Executive Director
Transaction date
Purchase
Price
15.00
Quantity 53,333 +inf%
Value US$799,995
0.8
YOUNG PHILIP M Non-Executive Director
Transaction date
Purchase
Price
15.00
Quantity 6,666 +23.1%
Value US$99,990
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-04 2026-03-02 S Sale
3.2
Cordonnier Michael

CEO, President

Executive Director
34,521 -28.6%
28.48
US$3,486,864 		34,521 -28.6% 28.48 US$3,486,864
2026-03-02 2026-03-02 PrS Proposed sale
3.2
Cordonnier Michael

Officer; Director

Executive Director
38,958
472.77
US$1,093,404 		38,958 472.77 US$1,093,404
2025-07-24 2025-07-24 B Purchase
0.8
B CAPITAL GROUP MANAGEMENT, L.P.
Large shareholder
79,979 -39.0%
127.14
US$3,716,231 		79,979 -39.0% 127.14 US$3,716,231
2025-07-24 2025-07-24 B Purchase
0.8
Mittendorff Robert II
Non-Executive Director
1,333,333 +36.2%
15.00
US$19,999,995 		1,333,333 +36.2% 15.00 US$19,999,995
2025-07-24 2025-07-24 B Purchase
0.8
Sidow Kevin
Non-Executive Director
13,333 +28.8%
15.00
US$199,995 		13,333 +28.8% 15.00 US$199,995
2025-07-24 2025-07-24 B Purchase
2.6
ROOT JONATHAN D
Non-Executive Director
466,666 +2692.4%
15.00
US$6,999,990 		466,666 +2692.4% 15.00 US$6,999,990
2025-07-24 2025-07-24 B Purchase
0.8
YOUNG PHILIP M
Non-Executive Director
53,333 +inf%
15.00
US$799,995 		53,333 +inf% 15.00 US$799,995
2025-07-24 2025-07-24 B Purchase
0.8
YOUNG PHILIP M
Non-Executive Director
6,666 +23.1%
15.00
US$99,990 		6,666 +23.1% 15.00 US$99,990
Explore more

More insider trading research around Carlsmed Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America